Open Collections

Seth, Jayant; Sharma, Sohat; Leong, Cameron J.; Vaibhav, Venkat; Nelson, Pierce; Shokravi, Arveen; Luo, Yuchen; Shirvani, Daniel; Laksman, Zachary

Multidisciplinary Digital Publishing Institute

The purpose of this review is to summarize the current understanding of the therapeutic effect of stem cell-based therapies, including hematopoietic stem cells, for the treatment of ischemic heart damage. Following PRISMA guidelines, we conducted electronic searches in MEDLINE, and EMBASE. We screened 592 studies, and included RCTs, observational studies, and cohort studies that examined the effect of hematopoietic stem cell therapy in adult patients with heart failure. Studies that involved pediatric patients, mesenchymal stem cell therapy, and non-heart failure (HF) studies were excluded from our review. Out of the 592 studies, 7 studies met our inclusion criteria. Overall, administration of hematopoietic stem cells (via intracoronary or myocardial infarct) led to positive cardiac outcomes such as improvements in pathological left-ventricular remodeling, perfusion following acute myocardial infarction, and NYHA symptom class. Additionally, combined death, rehospitalization for heart failure, and infarction were significantly lower in patients treated with bone marrow-derived hematopoietic stem cells. Our review demonstrates that hematopoietic stem cell administration can lead to positive cardiac outcomes for HF patients. Future studies should aim to increase female representation and non-ischemic HF patients.

Article

eng

Vancouver : University of British Columbia Library

10.14288/1.0444145

Applied Science, Faculty of; Medicine, Faculty of; Other UBC; Non UBC; Biomedical Engineering, School of

10.3390/ijms25126634

Faculty; Researcher; Graduate

DSpace